Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

Daniele Santini; Anna Maria Frezza; Olga Venditti; Salvatore Intagliata; Emanuela Dell'aquila; Francesco Guida; Bruno Vincenzi; Giuseppe Tonini

doi:10.1517/14728222.2013.773269

Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

Daniele Santini, Anna Maria Frezza, Olga Venditti, Salvatore Intagliata, Emanuela Dell'aquila, Francesco Guida, Bruno Vincenzi, Giuseppe Tonini

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	473-474
Number of pages	2
Journal	Expert Opinion on Therapeutic Targets
Volume	17
Issue number	4
DOIs	https://doi.org/10.1517/14728222.2013.773269
Publication status	Published - Apr 2013

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Clinical Biochemistry
Molecular Medicine

Access to Document

10.1517/14728222.2013.773269

Cite this

Comment and reply on : Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens. / Santini, Daniele; Frezza, Anna Maria; Venditti, Olga; Intagliata, Salvatore; Dell'aquila, Emanuela; Guida, Francesco; Vincenzi, Bruno; Tonini, Giuseppe.

In: Expert Opinion on Therapeutic Targets, Vol. 17, No. 4, 04.2013, p. 473-474.

Research output: Contribution to journal › Article › peer-review

Santini, Daniele ; Frezza, Anna Maria ; Venditti, Olga ; Intagliata, Salvatore ; Dell'aquila, Emanuela ; Guida, Francesco ; Vincenzi, Bruno ; Tonini, Giuseppe. / Comment and reply on : Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens. In: Expert Opinion on Therapeutic Targets. 2013 ; Vol. 17, No. 4. pp. 473-474.

@article{f3b6bb24b67b445799f889e1ba1505cf,

title = "Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens",

author = "Daniele Santini and Frezza, {Anna Maria} and Olga Venditti and Salvatore Intagliata and Emanuela Dell'aquila and Francesco Guida and Bruno Vincenzi and Giuseppe Tonini",

year = "2013",

month = apr,

doi = "10.1517/14728222.2013.773269",

language = "English",

volume = "17",

pages = "473--474",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Comment and reply on

T2 - Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

AU - Santini, Daniele

AU - Frezza, Anna Maria

AU - Venditti, Olga

AU - Intagliata, Salvatore

AU - Dell'aquila, Emanuela

AU - Guida, Francesco

AU - Vincenzi, Bruno

AU - Tonini, Giuseppe

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84875191769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875191769&partnerID=8YFLogxK

U2 - 10.1517/14728222.2013.773269

DO - 10.1517/14728222.2013.773269

M3 - Article

C2 - 23445337

AN - SCOPUS:84875191769

VL - 17

SP - 473

EP - 474

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 4

ER -

Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this